Cite
MLA Citation
Jonathan Barratt et al.. “MO212: Updated Interim Results of A Phase 1/2 Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Activity of BION-1301 in Patients With IGA Nephropathy.” Nephrology dialysis transplantation, vol. 37, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100158000745.0x00004a